Fort Lee, NJ, United States of America

Slavik Dushenkov

This inventor holds 3 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Rutgers, The State University of New Jersey, Wellgen, Inc., Regents of the University of Minnesota. Active years: 2006-2008.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Slavik Dushenkov. Retrieved from https://idiyas.com/inventor/slavik-dushenkov

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

 


Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 43(Granted Patents)


Company Filing History:


Years Active: 2006-2008

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Slavik Dushenkov

Introduction

Slavik Dushenkov is a notable inventor based in Fort Lee, NJ (US). He has made significant contributions to the field of bioactive compounds and their applications in health and medicine. With a total of 3 patents, Dushenkov's work focuses on developing novel compounds that can aid in the prevention and treatment of various conditions, including cancer and inflammatory diseases.

Latest Patents

Dushenkov's latest patents include innovative formulations and methods. One of his key inventions is related to bioactive compounds and methods of uses thereof. This invention provides compounds with specific formulas that can be utilized for the prevention or treatment of cancer. Another significant patent involves benzotropolone derivatives and modulation of inflammatory response. This invention presents novel benzotropolone derivatives that serve as effective antioxidant and anti-inflammatory agents. Additionally, it outlines methods for synthesizing these compounds in high yields and treating inflammatory conditions.

Career Highlights

Throughout his career, Slavik Dushenkov has worked with reputable institutions, including Rutgers, the State University of New Jersey, and Wellgen, Inc. His work in these organizations has allowed him to advance his research and contribute to the scientific community significantly.

Collaborations

Dushenkov has collaborated with esteemed colleagues such as Chi-Tang Ho and Robert T Rosen. These collaborations have further enriched his research and innovation efforts.

Conclusion

Slavik Dushenkov's contributions to the field of bioactive compounds and their applications are noteworthy. His innovative patents and collaborations highlight his commitment to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…